Cue Biopharma Inc. (NASDAQ: CUE) stock closed at 3.05 per share at the end of the most recent trading day (a 4.45% change compared to the prior day closing price) with a volume of 315.47K shares and market capitalization of 137.63M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 47 people. Cue Biopharma Inc. CEO is Daniel R. Passeri.

The one-year performance of Cue Biopharma Inc. stock is -7.3%, while year-to-date (YTD) performance is 7.02%. CUE stock has a five-year performance of -36.98%. Its 52-week range is between 1.7 and 5.12, which gives CUE stock a 52-week price range ratio of 39.47%

Cue Biopharma Inc. currently has a PE ratio of -2.10, a price-to-book (PB) ratio of 2.41, a price-to-sale (PS) ratio of 117.25, a price to cashflow ratio of -, a PEG ratio of -, a ROA of -65.40%, a ROC of -68.50% and a ROE of -89.51%. The company’s profit margin is -%, its EBITDA margin is -492.00%, and its revenue ttm is $1.09 Million , which makes it $0.03 revenue per share.

Of the last four earnings reports from Cue Biopharma Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.30 for the next earnings report. Cue Biopharma Inc.’s next earnings report date is -.

The consensus rating of Wall Street analysts for Cue Biopharma Inc. is Strong Buy (1), with a target price of $8.67, which is +184.26% compared to the current price. The earnings rating for Cue Biopharma Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Cue Biopharma Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

Cue Biopharma Inc. has a Buy technical analysis rating based on Technical Indicators (ADX : 15.26, ATR14 : 0.23, CCI20 : 246.92, Chaikin Money Flow : 0.08, MACD : 0.16, Money Flow Index : 77.02, ROC : 25.00, RSI : 70.92, STOCH (14,3) : 94.74, STOCH RSI : 1.00, UO : 56.44, Williams %R : -5.26), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Cue Biopharma Inc. in the last 12-months were: Daniel R. Passeri (Buy at a value of $8 580), Peter A. Kiener (Sold 0 shares of value $-27 691 ), Peter A. Kiener (Sold 9 325 shares of value $30 586 ), Suri Anish (Buy at a value of $11 040)